Clinical trials
Phase 1 Psoriasis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 8 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 6 |
| 2019 | 7 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 49 |
| Terminated | 10 |
| Recruiting | 4 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 5 |
| Eli Lilly and Company | 5 |
| AbbVie | 4 |
| Bausch Health Americas, Inc. | 3 |
| Astellas Pharma Inc | 2 |
| Centocor, Inc. | 2 |
| Janssen Research & Development, LLC | 2 |
| Mayne Pharma International Pty Ltd | 2 |
| Prothena Biosciences Limited | 2 |
| Wake Forest University Health Sciences | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Psoriasis | 67 |
| Arthritis, Rheumatoid | 5 |
| Arthritis, Psoriatic | 4 |
| Dermatitis, Atopic | 4 |
| Lupus Erythematosus, Systemic | 4 |
| Autoimmune Diseases | 3 |
| Inflammatory Bowel Diseases | 3 |
| Colitis, Ulcerative | 2 |
| Crohn Disease | 2 |
| Inflammation | 2 |
Trials
Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.